Home / Blog / IotaMotion Receives $2 Million in Seed Financing for CI Surgery Technology


  • IotaMotion Receives $2 Million in Seed Financing for CI Surgery Technology
    18 Aug , 2017






    IotaMotion Receives $2 Million in Seed Financing for CI Surgery Technology


    IotaMotion a medical device startup focused on hearing loss treatment that was spun out from theUniversity of Iowa’s Otolaryngology Department,announced that the company has raised $2 million in a seed financing round to fuel the development of novel robotic systems for cochlear implantation surgery.

    The iotaMotion technology will enable surgeons to achieve more precise, individualized solutions for patients experiencing various types of hearing loss, according to iotaMotion. IOTA-Soft—the company’s robotic-assisted insertion device—will reportedly allow surgeons to advance cochlear implant electrodes with the precision of robotics. Controlled insertion will allow for less surgical variability in outcomes and results, helping to protect existing structures from the damage of manual insertion. This is especially critical when working with hybrid hearing solutions where the patient has retained residual hearing capacity.

    “We’ve completed our seed round, raising over $2 millionwithin a few months from friends and family in the Midwest and around the world,” said Chris Kaufmann, MD, and co-founder of iotaMotion. “The reception and excitement from both the cochlear implant community and strategic investors is a testament to the clear clinical need and the surgeon-centric, robotics-assisted systems we are developing. The funds will be used to further our development efforts for the IOTA-Soft robotic-assisted cochlear implant insertion system.”

    “The core technology being developed at iotaMotion is notable in its simplified approach to robotic-assisted systems,” said Marlan Hansen, MD, and co-founder of iotaMotion. “Our aim is to develop devices that open up access to cochlear implant surgery for a wider audience of both surgeons and patients. We are especially grateful for the local and regional support that we received early on from the University of Iowa and the state, to help us get to this point.”

    “We are thrilled to have such strong support for the vision of iotaMotion, and we look forward to building on our work to-date,” said Eric B. Timko, executive chairman of iotaMotion. “We will be investing in resources to expand our research and development efforts along with the kind of quality and regulatory initiatives that are imperative in medical technology companies.”

    Source: iotaMotion
    Image: iotaMotion